CYTODEL
CytoDel is a biopharmaceutical company that uses the tools of 21st-century molecular biology to produce recombinant derivatives of botulinum neurotoxin (BoNT) customized to specific applications. The technology allows CytoDel to manipulate the BoNT molecule, for next-generation BoNT products and into a drug delivery vehicle that can deliver therapeutic molecules to the inside of neurons. Biodefense is our top priority but CytoDel is developing programs to advance the treatment of nervous system disorders, chronic pain, and neurodegenerative diseases.
CYTODEL
Industry:
Biopharma Health Care Pharmaceutical Therapeutics
Founded:
2012-01-01
Address:
New York, New York, United States
Country:
United States
Website Url:
http://www.cytodel.com
Total Employee:
1+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
225 K USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SSL By Default Google Font API LetsEncrypt Content Delivery Network Font Awesome Euro Amazon Google Apps For Business
Similar Organizations
Chaperone Therapeutics
Chaperone Therapeutics is developing frontline therapies to address diseases of protein misfolding
NephroDI Therapeutics
NephroDI Therapeutics is a biopharmaceutical company that focuses on the concentration disorders of the kidney.
Palo Santo Fund
Palo Santo Fund is an investment fund that invests in psychedelic and healthcare industry.
Current Advisors List
Current Employees Featured
Founder
Investors List
Small Business Innovation Research
Small Business Innovation Research investment in Grant - Cytodel
Official Site Inspections
http://www.cytodel.com
- Host name: unalocated.63.wixsite.com
- IP address: 185.230.63.171
- Location: Ashburn United States
- Latitude: 39.018
- Longitude: -77.539
- Metro Code: 511
- Timezone: America/New_York
- Postal: 20147
